Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aSAH-ASA: Early Prophylactic Aspirin in Aneurysmal Subarachnoid Hemorrhage
NCT07642427Phase 4Not yet recruiting
- Sponsor
- Ganzhou People's Hospital
- Start
- Jun 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in aneurysmal subarachnoid hemorrhage (SAH), delayed cerebral ischemia (DCI), sponsored by Ganzhou People's Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)delayed cerebral ischemia (DCI)
Beyond the preview
Go deeper on NCT07642427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07642427.